Bill Motto

In a report published Monday, Canaccord Genuity analyst Mark Massaro hosted an investor meeting with Meridian Bioscience, Inc. (NASDAQ: VIVO)'s Chief Financial Officer Melissa Lueke which left the analyst "encouraged" as the company appears to be "energized" and on a new strategic path. According...